Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 89 of 95, showing 5 Applications out of 471 total, starting on record 441, ending on 445

# Protocol No Study Title Investigator(s) & Site(s)

441.

ECCT/18/12/02   Randomized Controlled Trial to Compare the Effect of Corn-Soy Blend + Vegetable Oil 8 and Fish Oil (CSB-VO-FO) With Corn-Soy Blend + Vegetable Oil Alone (CSB-VO) on 9 the Immunological and Microbiota Patterns among Children Aged 6 to 24 months with 10 Mod
    Randomized Controlled Trial to Compare the Effect of Corn-Soy Blend + Vegetable Oil 8 and Fish Oil (CSB-VO-FO) With Corn-Soy Blend + Vegetable Oil Alone (CSB-VO) on 9 the Immunological and Microbiota Patterns among Children Aged 6 to 24 months with 10 Mod   
Principal Investigator(s)
1. CHRISTOPHER L. MELBY MELBY
Site(s) in Kenya
KENYA MEDICAL RESEARCH INSTITUTE
 
View

442.

ECCT/14/04/01   REACH Trial
    REALIZING EFFECTIVENESS ACROSS CONTINENTS WITH HYDROXYUREA (REACH):  A PHASE I/II PILOT STUDY OF HYDROXYUREA FOR CHILDREN WITH SICKLE CELL ANAEMIA.   
Principal Investigator(s)
1. Thomas Neil Williams
Site(s) in Kenya
Kilifi County Hospital
 
View

443.

ECCT/12/09/02   Reduction of EArly mortaLITY in adults and children
    Reduction of EArly mortaLITY in HIVinfected adults and children starting antiretroviral therapy (REALITY)   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Wellcome Trust Research Programme (Kilifi county)
 
View

444.

ECCT/16/12/02   Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis:
    Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial.   
Principal Investigator(s)
1. ISAAC TSIKHUTSU
Site(s) in Kenya
KEMRI/WRP, KERICHO
 
View

445.

ECCT/22/05/03   Anti-malaria MAb in Kenyan chi
    Safety and Efficacy of L9LS, a Human Monoclonal Antibody Against Plasmodium falciparum, in an Age De-Escalation, Dose-Escalation Trial and a Randomized, Placebo-Controlled, Double-Blind Trial of Children in Western Kenya   
Principal Investigator(s)
1. Titus Kwambai
2. Laura Steinhardt
3. Robert A Seder
Site(s) in Kenya
1. Siaya County Referral Hospital (Siaya county)
2. Kogelo Health Center (Siaya county)
 
View